The Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi 214122, China; National Engineering Laboratory for Cereal Fermentation Technology, Jiangnan University, Wuxi 214122, China.
China Agricultural Veterinary Biological Science and technology Co., Ltd, Lanzhou 730046, China.
J Pharm Sci. 2019 Jul;108(7):2288-2295. doi: 10.1016/j.xphs.2019.02.004. Epub 2019 Feb 19.
Quality by design (QbD) principle has been established as a guideline to emphasize the understanding of the relationship of product quality with process control. Vaccine product have characteristics of security and high efficiency, but it also has features such as complexity and rigorous regulatory for production. This case study describes an example of QbD-driven process development for manufacturing a veterinary vaccine produced with baby hamster kidney-21 cells. The study revealed that cell culture duration was the most significant factor affecting 50% tissue culture infectious doses (TCID) and antigenic titer, and the factors of culture temperature and pH at infection phase exhibited less effect. Culture temperature at infection phase was the only significant factor for total protein. Through the Monte Carlo simulation, the design spaces of process parameters were determined. Meanwhile, the excellent and robust performance in manufacturing scale (4000-L) validated the effectiveness of this strategy. A reliable and robust multivariate process parameter range, that is, design space, was identified by this systematic approach. Our investigation presents a successful case of QbD principle, which encourages other researchers to combine the methodology into other biopharmaceutical manufacturing process.
质量源于设计(QbD)原则已被确立为指导方针,强调了产品质量与过程控制关系的理解。疫苗产品具有安全性和高效性的特点,但也具有生产过程复杂和监管严格等特点。本案例研究描述了一个利用仓鼠肾细胞-21 生产兽用疫苗的 QbD 驱动的工艺开发示例。研究表明,细胞培养时间是影响 50%组织培养感染剂量(TCID)和抗原滴度的最显著因素,感染阶段的培养温度和 pH 值的因素影响较小。感染阶段的培养温度是总蛋白的唯一显著因素。通过蒙特卡罗模拟,确定了工艺参数的设计空间。同时,在制造规模(4000-L)上的出色和稳健性能验证了该策略的有效性。通过这种系统的方法,确定了可靠和稳健的多元过程参数范围,即设计空间。我们的研究提出了 QbD 原则的成功案例,鼓励其他研究人员将该方法结合到其他生物制药制造工艺中。